BRIEF-Tigenix provides update on Cx601 marketing authorization application procedure in Europe
March 6 Tigenix Nv:
* Tigenix provides update on Cx601 marketing authorization application procedure in Europe
* Announces that it has received Day 180 List Of Outstanding Issues (LOOI) from Committee for Medicinal Products for Human Use (CHMP) of European Medicines Agency (EMA)
* Expects to receive a marketing authorization decision for Cx601 in 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
UPDATE 1-Germany plans new emissions testing body after VW scandal
BERLIN, June 27 The German transport ministry announced plans on Tuesday to set up a new institute to test vehicle emissions to try to restore consumer confidence after the Volkswagen scandal.